Delivery Order SPE2DB22D3501-SPE2DB24FWT48

Award Date 8/23/24
Potential Completion Date 8/26/24
Potential Value $4.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of DIPRIVAN 500 MG/50 ML VIAL 50ML, a pharmaceutical product, with a ceiling value of $4,980.18 and a period of performance through May 22, 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DIPRIVAN 1,000 MG/100 ML VIAL 100ML, a medical product, with a ceiling value of $1,078.88 and a period of performance through April 7, 2025. The contract is a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition....
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of DIPRIVAN 1,000 MG/100 ML VIAL 100ML, a medical product, with a ceiling value of $5,265.14 and a period of performance through May 22, 2025. The contract is a firm fixed-price type, without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $10,295.08, is for the delivery of DIPRIVAN 1,000 MG/100 ML VIAL 100ML, a medical product. The contract is a firm fixed-price delivery order, with a completion date of March 14, 2025. It is not designated as a set-aside contract. AmerisourceBergen holds a larger Indefinite Delivery Contract...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of DIPRIVAN 1,000 MG/100 ML VIAL 100ML, a pharmaceutical product. The contract has a firm fixed price of $5,552.61 and a completion date of November 22, 2024. The award is not designated as a set-aside. AmerisourceBergen Drug Corporation is a major pharmaceutical distributor that provides a comprehensive range of medical products and supplies to the federal government,...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, by the Defense Logistics Agency (DLA). The contract is for the supply of 4,564,443,643 units of the pharmaceutical product DIPRIVAN 1,000 MG/100 ML VIAL 100ML. The contract has a ceiling value of $2,630.99 and a completion date of May 1, 2024. This contract is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 that Amerisourcebergen holds with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of DIPRIVAN 1,000 MG/100 ML VIAL 100ML, a critical care medication, with a ceiling value of $1,178.58 and a period of performance through September 23, 2024. This contract is not set aside for any specific business type. Amerisourcebergen, through its extensive supply chain network, has been awarded numerous federal...
This is a delivery order contract awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of DIPRIVAN 200 MG/20 ML VIAL 20ML, a pharmaceutical product. The contract has a firm fixed price of $9,635.59 and a completion date of November 27, 2024. Amerisourcebergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that plays a critical role in supplying medical products to federal government agencies. This contract is not...
This is a $2,161.86 delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the provision of DIPRIVAN 1,000 MG/100 ML VIAL 100ML, a critical medical commodity, to support military healthcare programs. The contract has an ultimate completion date of April 30, 2024 and is a firm fixed-price contract. This award is associated with a larger $999,999,999 Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of DIPRIVAN 1,000 MG/100 ML VIAL 100ML. The contract has a ceiling value of $1,166.54 and is a firm fixed price delivery order contract. It has an ultimate completion date of June 5, 2024. The contract is not set aside and is an award under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
  • SPE2DB22D3501
    Indefinite Delivery Contract
  • SPE2DB22D3501-SPE2DB24FWT48
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, Corporate Office Division. The contract has a ceiling value of $4,097.46 and is for the delivery of DIPRIVAN 1,000 MG/100 ML VIAL 100ML, a critical pharmaceutical product. The contract is a firm-fixed price instrument with an ultimate completion date of August 26, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded this delivery order as part of its Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which is valued at up to $999,999,999 through December 2025. This IDC enables the DLA to efficiently procure a wide range of essential medical commodities, including pharmaceuticals, to support military treatment programs and facilities worldwide. The contract does not have a set-aside designation.

Generated 11/22/24, 9:23 AM